Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy: an academic centre experience

Depending on the severity of clinical condition, acute pulmonary embolism (APE) is treated with unfraction-ated heparin (UFH), low-molecular weight heparin (LMWH), oral anticoagulants or, in the most severe form, with fibrinolytic agents. Following APE, patients require prolonged anticoagulant thera...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kardiologia polska 2016-01, Vol.74 (7), p.650-656
Hauptverfasser:	Paczyńska, Marzanna, Kurnicka, Katarzyna, Lichodziejewska, Barbara, Goliszek, Sylwia, Dzikowska-Diduch, Olga, Sobieraj, Piotr, Burzyński, Łukasz, Kostrubiec, Maciej, Pruszczyk, Piotr, Ciurzyński, Michał
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Factor Xa Inhibitors - therapeutic use Female Humans Length of Stay Male Middle Aged Pulmonary Embolism - drug therapy Rivaroxaban - therapeutic use Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!